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ABSTRACT
Background Imaging tests are one of the most 
frequently used diagnostic modalities in healthcare, but 
the benefits of their direct impacts on clinical decision- 
making have been countered by concerns that they can 
be overused. Assessing the relative value of imaging tests 
has largely focused on measures of test accuracy, which 
overlooks more comprehensive benefits and risks of 
imaging tests, particularly their impact on patient- centred 
outcomes (PCOs). We present the findings of the Patient 
Reported Outcomes of Diagnostics (PROD) research 
study in response to a methodological gap in the area of 
diagnostic test comparative effectiveness research.
Methods Over a 3- year period, the PROD Study 
engaged with multiple stakeholders to identify existing 
conceptual models related to PCOs for imaging testing, 
conducted primary research and evidence synthesis, and 
developed consensus recommendations to describe and 
categorise PCOs related to imaging testing.
Results The PROD framework categorises PCOs from 
imaging studies within four main domains: information or 
knowledge yielded, physical impact, emotional outcomes 
and test burden. PCOs interact with each other and 
influence effects across domains, and can be modified by 
factors related to the patient, clinical situation, healthcare 
team and the testing environment.
Conclusions Using PCOs to inform healthcare decision- 
making will require ways of collating and presenting 
information on PCOs in ways that can inform patient–
provider decision- making, and developing methods to 
determine the relative importance of outcomes (including 
test accuracy) to one another.
INTRODUCTION
Multiple frameworks have been devel-
oped to evaluate diagnostic tests, which 
typically include generating evidence 
across phases of technical efficacy, test 
accuracy, diagnostic efficacy, therapeutic 
efficacy, patient outcome and societal 
aspects.1–4 While test accuracy plays a 
pivotal role for clinical outcomes and 
regulatory approval, there have been 
repeated demands for more comprehen-
sive methods to evaluate the benefits 
and risks of diagnostic tests in terms of 
patient- centred outcomes (PCOs).5
The concept that tests can impact 
patient well- being, in addition to ‘clinical’ 
outcomes,6 has mainly been explored in 
the context of impacts of false positive 
screening test results.7–9 There have been 
few attempts to systematically determine 
which PCOs are important to patients 
undergoing testing, nor the extent to which 
these outcomes are shared across different 
types of tests, and how these outcomes 
can be used as part of shared decision- 
making. Patient- centred care is based on 
the understanding that PCOs include 
topics that patients themselves identify as 
important,10 which in turn can be used to 
drive service improvements by comparing 
performance on outcome metrics that 
matter to patients.11 12 While this concept 
has been applied to comparative effective-
ness research of interventions, it has rarely 
been applied to diagnostic tests.5
The Patient Reported Outcomes of 
Diagnostics (PROD) Study13 aimed to 
develop consensus- based recommenda-
tions to guide methods for incorporating 
PCOs within comparative effectiveness 
research of diagnostic tests. We focused 
on imaging testing, given that this is one 
of the most frequently used modalities of 
testing in healthcare, yet faces concerns 
of overuse and rising costs.9 14 15 We used 
primary research, evidence syntheses 
and input from multiple stakeholders 
to describe and categorise PCOs from 
imaging tests with a goal of informing 
clinical care, research and policy.




Our approach was based on the multistep processes 
used to develop consensus methods and research 
reporting guidelines.12 16–18 Over a 3- year period, 
we: (1) confirmed the methodology gap and identi-
fied relevant conceptual models and frameworks, (2) 
recruited and engaged stakeholders, (3) identified 
PCOs currently used in clinical recommendations for 
imaging testing, (4) conducted qualitative research with 
patients and healthcare providers to identify PCOs, 
(5) conducted a scoping review of PCOs from existing 
qualitative literature, and (6) developed consensus- 
based recommendations on PCOs of imaging testing 
(figure 1).19 We considered that consensus methods 
provided two advantages over other methods (such as 
Delphi or nominal group technique): first, allowing 
synthesis of the best available information; and 
second, allowing a process of consensus and validation 
between key stakeholders.20
Confirmation of methodology gap and identification of relevant 
conceptual models and frameworks
We used an iterative process to identify published 
literature that had attempted to address the method-
ological gap, including an extensive search of existing 
research on diagnostic test evaluation and imaging 
tests specifically. This was used to provide additional 
justification for the proposed research and identify any 
additional evaluation frameworks for diagnostic tests, 
conceptual models outlining the range of PCOs that 
may occur with testing, and literature specific to PCOs 
from imaging tests. We used a non- systematic scan 
of the literature search, including existing systematic 
reviews,1–8 input from methods experts and focused 
hand- searching.
Figure 1 Data sources and methods used to develop final recommendations. Note: This figure was created by the authors and no persmission is required.
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Stakeholder recruitment and engagement
We adopted the Six- Stage Model for Patient- Centered 
Outcomes Research and Comparative Effectiveness 
Research to guide stakeholder engagement.21 Stake-
holders were selected from the following: (1) patients 
and patient advocates with support from a patient 
advisory network (http:// becertain. org/ partnerships/ 
patient- advisory- network); (2) primary care clinicians 
and radiology staff from the Washington, Wyoming, 
Alaska, Montana and Idaho Practice and Research 
Network; (3) the American College of Radiology 
(ACR); (4) consumer advocates; (5) imaging industry 
and (6) diagnostic methods experts. Recruitment was 
based on a combination of outreach through national, 
regional and local organisations. The stakeholders 
guided research direction, informed data collection 
instruments, interpreted findings and contributed 
to research outputs.22 23 Additionally, stakeholders 
attended a 2- day meeting to develop the final recom-
mendations.
Identification of PCOs currently used in clinical recommendations
In order to identify the frequency and type of PCOs 
reported in studies of imaging testing that are used 
to inform clinical recommendations, we conducted a 
secondary analysis of studies included in the ACR’s 
Diagnostic Imaging Appropriateness Criteria which 
are used by referring physicians and radiologists to 
guide imaging test decisions and are incorporated 
into clinical decision support mechanisms. We used 
a broad definition of PCOs used by Patient Centered 
Outcomes Research Institute (PCORI) and modified 
by other researchers in this field.5 6 24 We searched for 
PCOs reported in articles published across all clinical 
areas relevant to the PROD Study (ie, excluding paedi-
atric and obstetric imaging, interventional radiology), 
and used systematic methods to extract and synthesise 
data.25 26
Qualitative research with patients and healthcare providers to identify 
PCOs
We conducted semistructured interviews with 45 
patients who had undergone imaging studies across 
a variety of conditions and imaging modalities, 16 
primary care providers, and 16 radiologists and radi-
ology technologists to seek their experiences and 
perceptions of PCOs.25 27 Patients and clinicians were 
recruited from primary care clinical sites and radiology 
offices affiliated with the Washington, Wyoming, 
Alaska and Montana Practice and Research Network 
(WPRN). This research also aimed to identify factors 
that could influence the perceived importance of these 
outcomes for patients.28
Scoping review of PCOs from existing qualitative literature
A scoping review of qualitative studies reporting 
PCOs from imaging studies was used to broaden 
the evidence base of PCOs beyond those identified 
from our primary research. We searched for studies 
reporting PCOs across multiple imaging modalities 
and clinical settings. The review aimed to identify 
relevant studies that had explored patients’ emotions, 
knowledge, and physical preferences in relation to 
imaging tests either before, during, or after imaging 
testing. The scoping review, described in full in online 
supplemental appendix 1, identified and synthesised 
qualitative research that had reported PCOs from any 
type of imaging modality, clinical setting and patient 
group.29–31
Development of consensus-based recommendation on PCOs for 
imaging testing
At the end of the 3- year period, 28 stakeholders (online 
supplemental appendix 2) participated in a 2- day 
meeting held in Seattle, Washington, which aimed to 
define and categorise PCOs related to imaging testing, 
and provide recommendations for next steps needed 
to implement PCOs in decision- making. We followed 
the five key elements of consensus methods as outlined 
by Black et al.32 (1) Approach to the task: the open- 
ended study goals were chosen to avoid influencing 
judgement or selectivity of the stakeholders, and our 
process included research evidence, experience of 
consumers (in this case, patients/caregivers) and clin-
ical expertise (in this case, the primary care, radiolo-
gists and other stakeholders).33 (2) Participant selec-
tion: one of the most important components of our 
consensus method was engaging multiple stakeholders, 
as described above, representing different potential 
viewpoints and expertise on PCOs. We considered this 
would provide a range of values, beliefs and experi-
ences.20 (3) Presentation of scientific data: we used 
the regular stakeholder meetings to engage stake-
holders across the entire lifespan of this research. 
This included direct involvement with developing 
the primary research studies, input to findings from 
the primary research (including as coauthors), and 
presenting emerging descriptions and details of PCOs 
as they emerged. (4) Structure of the interaction: 
stakeholder meetings were facilitated by research staff 
with experience in patient engagement and occurred 
approximately quarterly teleconference for the initial 
study period of 2 ½ years. We held additional meet-
ings only attended by patients and caregivers, with 
the same frequency over this period, to allow their 
voices to be fully heard. (5) Method of synthesising 
data: we aimed to achieve conclusions regarding the 
definition and categorisation of PCOs using a reflexive 
and iterative process.34 Over the initial 2 ½ years of 
the research period, we synthesised findings from the 
emerging research at quarterly stakeholder meetings, 
developing and publishing in peer- reviewed literature 
the emerging findings. The 2- day in- person conference 
aimed to debate and review proposed final definitions 
and categorisation of PCOs, and provide recommen-
dations for next steps needed to implement PCOs in 
4 Thompson MJ, et al. BMJ Qual Saf 2021;0:1–10. doi:10.1136/bmjqs-2021-013311
Original research
decision- making. We did not intend to use this meeting 
to eliminate or rank importance of PCOs. Prior to the 
meeting, stakeholders received preparatory material 
including descriptions of PCOs that had emerged 
during the previous 2 ½ years, and lay summaries 
of additional publications. During the meeting, the 
research team presented the draft materials and used 
small group breakout sessions, to seek input on both 
the clarity of these definitions and whether any PCOs 
had been overlooked or missed out. We also used small 
groups to attempt to identify the best way to catego-
rise the PCOs. Following the meeting, multiple written 
drafts of the consensus recommendations were distrib-
uted to stakeholders, and agreement was reached on 
the final document from all stakeholders.
Role of funding source
The work was funded by the PCORI, which approved 
the research plan submitted by the research team, but 
had no input to the research methods, findings, devel-
opment of consensus recommendations, nor in prepa-
ration or approval for any manuscripts submitted for 
publication.
Human subjects approval
All primary qualitative studies conducted by the 
authors, which are referenced in this manuscript, were 
approved by the University of Washington Division 
of Human Subject as documented in those publica-
tions.25 27 28 The activities of this consensus manuscript 
(including scoping review and systematic review) were 
determined to not involve human subjects and did not 
require additional IRB approval.
RESULTS
Confirmation of the methodology gap and 
identification of relevant conceptual models and 
frameworks
We identified several recommendations from groups 
such as guideline development organisations from 
the USA and Europe, and the Grading of Recom-
mentations Assessment, Development and Evaluation 
(GRADE) Working Group that supported a need for 
methods to measure the effects of tests on PCOs.5 18 35 
The need for methods to broaden the evaluation of 
imaging testing was identified in several publications, 
including limitations in reporting of imaging test 
research.9 36 Several studies had suggested a range of 
potential PCOs from diagnostic tests, but none had 
defined these in a systematic way.6–9 37 This step of the 
process therefore confirmed that the methods gap that 
PCORI had identified had not been addressed in other 
publications.
Identification of PCOs currently used in clinical 
recommendations for imaging testing
The secondary analysis of the ACR Appropriateness 
Criteria identified 89 eligible studies; these covered a 
wide range of clinical areas and imaging modalities.26 
The most frequent PCOs identified were: concerns 
about radiation exposure (n=37), the need for addi-
tional testing following an initial test (n=20), test 
complications (n=19), and indeterminate or inci-
dental findings (n=10). Other PCOs included quality 
of life (n=7), physical discomfort (n=5), patient 
values and experiences (n=4), patient financial and 
time costs (n=4), psychosocial outcomes (eg, depres-
sion, anxiety, claustrophobia) (n=4) and test duration 
(n=2) This analysis highlighted that relatively few 
PCOs are included in studies that underpin this set of 
clinical recommendations. The outcomes identified 
were mainly related to immediate or short- term health 
complications from the test process itself, and rarely 
reported from patients themselves.
Qualitative research with patients and healthcare 
providers to identify PCOs
Analysis of interviews with 45 patients, 16 primary 
care providers, and 16 radiologists and radiology tech-
nologists identified four themes related to PCOs.25 27 38 
These were: (1) information or knowledge gained from 
the test to address patients’ questions and to facilitate 
next steps in their healthcare; (2) physical experiences 
during the test procedure, such as discomfort or poten-
tial adverse effects; (3) positive and negative impacts 
of the testing process on patients’ emotions; and (4) 
the direct and indirect financial burden of testing. 
This research also highlighted factors that might influ-
ence outcomes, such as the effectiveness and content 
of patient–provider communication, impact of radi-
ology staff, and patients’ previous testing experience, 
underlying health, level of knowledge, expectations of 
the imaging test, insurance status, and cultural back-
ground.
Scoping review of PCOs from existing qualitative 
literature
We identified 25 qualitative studies that described PCOs, 
mainly focusing on mammography and MRI scanning, 
and most related to cancer screening, conducted in 
multiple countries (online supplemental appendix 1). 
We identified PCOs in three main domains, namely: 
(1) knowledge or information yielded by the imaging 
test including the desire to know what is wrong, irre-
spective of the finding, and a desire to know what indi-
viduals might experience both during test preparation 
and the procedure itself; (2) the emotional impact of 
the test both during preparatory stages and during the 
test, and the impact of compassion and empathy from 
radiology staff; and (3) physical discomfort associated 
with the testing procedure.
Development of consensus-based recommendation on 
PCOs of imaging testing
The stakeholder meeting facilitated discussion 
and feedback on proposed PCOs, domains and 
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recommendations. The PROD team developed a 
matrix which proposed PCOs occurring across a range 
of domains, before, during and after an imaging test. 
This matrix was shared with stakeholders to develop 
consensus regarding the full scope of potential PCOs 
and categorisation into potential domains. The main 
outcomes, described below, categorised PCOs within 
four domains, outlined how PCOs can potentially 
interact with each other and identified factors that can 
modify how they are experienced.
Domain 1: information or knowledge yielded by an 
imaging test
PCOs in this domain included test information that 
contributes to determining an underlying cause 
for patients’ symptoms or concerns, or informa-
tion that led to reducing the likelihood of a condi-
tion (table 1). In addition, patients described the 
value of knowing or seeing these results, regardless 
to some extent of what the imaging had revealed. 
Additional PCOs related to the impact of test results 
on decision- making, such as facilitating access 
to a higher level of care or a particular treatment 
course. There were also several negative outcomes, 
including: misleading information, particularly false 
positive tests prompting the need for additional 
testing to confirm/rule out a condition; inconclu-
sive or indeterminate results that did not provide a 
definitive diagnosis and could lead to further testing; 
and unexpected or incidental findings that might 
or might not have clinical significance, but require 
additional testing or investigations with associated 
burdens and impact on PCOs.
Domain 2: physical effects of the test or testing 
process
Preparing for imaging tests was associated with 
specific unpleasant experiences, such as undergoing 
bowel preparation prior to colonography (table 2). 
However, more prominent outcomes were pain and 
physical discomfort while undergoing the imaging 
procedure (eg, mammography), as well as its imme-
diate consequences. In some instances, the discom-
fort from an imaging modality depended on the area 
of the body being examined, for example, transvag-
inal versus abdominal ultrasound. Other physical 
outcomes included the effects of ionising radiation, 
which was mainly cited by patients undergoing 
frequent imaging.
Domain 3: emotional impact of the test or testing 
process
Tests used to evaluate new and/or concerning 
symptoms provided reassurance and relief when 
results ruled out certain conditions (table 3). Even 
in situations when results indicated an underlying 
Table 1 Patient- centred outcomes within domain of information or knowledge yielded by imaging tests
Outcomes Definition/explanation
Finding cause of symptoms  ► Finding out what is causing symptoms
 ► With a known diagnosis, information that leads to finding out how serious it is
 ► The desire for a definitive diagnosis, to reduce uncertainty
Reducing the probability of a condition that patient 
worried about
 ► Excluding a serious condition based on the test results
Value of just knowing or finding out more, whatever the 
outcome
 ► The desire to know, to find answers or just to find out/see something in their own body
Decision- making around the information given by the 
test, leading to action
 ► Test results facilitating access to higher level of care or proceed with a particular treatment 
course
False information from test results  ► Initial positive results leading to need for further tests (or a sequence of tests) to further 
confirm/rule out a condition (false positives)
 ► False reassurance from test results (false negatives)
Incidental and indeterminate findings  ► Indeterminate or inconclusive results leading to further downstream testing (‘testing 
cascade’) in attempts to arrive at a definitive diagnosis
 ► Unexpected findings that may or may not have clinical significance, but can lead to 
additional testing
This table was created by the authors and no permission is required.
Table 2 Patient- centred outcomes within domain of physical outcomes from imaging tests
Outcomes Definition/explanation
Preparation for the test  ► Undergoing preparation such as bowel preparation, or fasting, or ensuring full bladder
Physical discomfort, tolerability during the test  ► Pain from interventions or manipulation needed as part of testing procedure
 ► Bruising from body parts being compressed or held in certain positions
Longer term physical effects  ► Reactions to contrast material
 ► Cumulative effects of ionising radiation
This table was created by the authors and no permission is required.
6 Thompson MJ, et al. BMJ Qual Saf 2021;0:1–10. doi:10.1136/bmjqs-2021-013311
Original research
condition, some patients reported feelings of relief 
that they had found the cause of their concerns. 
However, testing also produced anxiety and negative 
emotional outcomes that could occur before the test 
(anticipation anxiety), and afterwards while waiting 
for results, and as a result of test findings. During 
the imaging procedure, the physical constraints, 
confined spaces, noise and unfamiliarity of the 
procedures could lead to feelings of claustrophobia 
and distress, as well as embarrassment from having 
to undress. On some occasions, negative emotional 
outcomes resulted from disappointment or regret 
about initiating testing, from test results that did not 
answer concerns or revealed information that did 
not advance their care.
Domain 4: test burden
Outcomes related to the direct or indirect burdens 
of imaging tests (table 4) included financial costs to 
patients, but these varied with the healthcare/health 
insurance system. These costs were particularly 
noted for complex imaging (MRI, CT, etc), and in 
situations where an initial, less costly, imaging test 
revealed findings that required more complex, and 
more expensive, subsequent imaging. Direct costs 
were not always expected or considered prior to 
the test itself, and few patients were aware of costs. 
Similarly, healthcare providers recognised the impor-
tance of cost, but lacked information about actual 
costs. Other test burdens included time off work 
and travel times particularly for patients living far 
from imaging centres. Occasionally, the results of 
imaging testing led to financial benefits to patients, 
for example, when imaging testing revealed condi-
tions related to occupational or other injuries.
Interactions between outcomes
In addition to the outcomes categorised within these 
four domains, PCOs interacted with, and influenced, 
outcomes in other domains. These interactions 
included, for example, knowledge or information 
provided by a test result (domain 1) influencing 
patients’ emotions (domain 3), or, a test that is more 
physically unpleasant (domain 2) that provides more 
valuable information (domain 1) than one that is 
less invasive. The pattern of interactions appeared 
to be complex and varied with factors such as test 
modality and clinical situation. Recognising these 
interactions exist suggests that weighing of risks and 
benefits across domains is likely to be challenging to 
incorporate into research or clinical care.
Modifiers of outcomes
Multiple factors potentially impacted or modified 
whether or not a PCO occurred, its severity, its 
relative importance and its impact on the patient 
(table 5).28 These ranged from the characteristics 
of the individual patient, the type of test they are 
undergoing, the clinical situation, as well as the 
healthcare providers involved, the physical envi-
ronment of the testing suite and communication 
of results. Embedded within several of these modi-
fiers was the concept of a patient’s prior (pretest) 
probability of a particular outcome or condition. 
Table 3 Patient- centred outcomes within domain of emotional outcomes from imaging tests
Outcomes Definition/explanation
Reassurance, relief  ► Relief or reassurance after finding symptoms not caused by serious condition
Anxiety, worry  ► Fear or anxiety waiting for testing to be performed and in anticipation of results
 ► Stress and anxiety while waiting to get test result
 ► Distress and other negative emotional impacts when test shows a serious condition, including false positive 
results
Claustrophobia, embarrassment  ► Claustrophobia, distress from imaging testing process (eg, narrowness of scanner, noise)
 ► Embarrassment or loss of modesty from exposing private body parts
Lack of control  ► Perceived lack of control over the test ordering, its conduct and the next steps the results lead to
 ► Feeling abandoned, isolated or helpless during the imaging test itself
Decisional regret, mismatch with 
expectations
 ► Frustration or regret about uncertain test results leading to further testing
 ► Disappointment in test results that do not provide the information or findings expected, or that leave residual 
uncertainty
This table was created by the authors and no permission is required.
Table 4 Patient- centred outcomes within domain of burden from imaging tests
Outcomes Definition/explanation
Financial costs of the test  ► Costs that the patient experiences directly or indirectly from the testing process itself
 ► Costs that arise from the clinical actions that the test leads to
 ► Potential financial benefits from workplace injuries or insurance or disability claims
Disruption to work or social 
life
 ► Disruption to work, school, social activities from waiting for test to be performed, and undergoing the test itself, and waiting for 
test results (eg, time off work)
This table was created by the authors and no permission is required.
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For example, a patient with a known history of a 
given condition may be at higher risk of recurrence 
(higher prior probability), whereas an asymptomatic 
individual being screened for that condition would 
be at a lower prior probability. These prior probabil-
ities can influence outcomes following the test result 
(such as greater anxiety in the emotion domain).
DISCUSSION
The Institute of Medicine highlighted that patient- 
centred practices are needed to address the psycho-
logical and social dimensions of patients’ healthcare 
concerns, in order to close quality gaps in health-
care.39 40 This study provides the first comprehensive 
attempt to define PCOs of imaging tests. We found 
that PCOs from imaging tests can be categorised into 
four domains: (1) information or knowledge yielded, 
(2) physical effects, (3) emotional outcomes and (4) 
test burden. We also noted that PCOs interact and 
influence each other in ways that are complex. More-
over, PCOs are not experienced identically; instead, 
they are influenced by factors related to the patient, 
the clinical environment and the physical environ-
ment of the test.
Our research advances an earlier concept that tests 
have more than ‘medical value’.6 7 41 42 While certain 
outcomes related to testing have been previously 
described, for example, emotional distress from false 
positive screening tests,43–45 a clear description and 
categorisation of PCOs related to imaging tests have 
largely been overlooked.4647
A strength of our recommendations is that they 
were informed by a wide body of primary and 
secondary research, and relied also on extensive 
input from a range of stakeholders, and are appli-
cable to imaging testing generally, rather than one 
type of test (eg, screening) or a single imaging 
modality. We used consensus methods, following 
key steps that have been recommended for this type 
of process.32 Furthermore, a key area of guidance 
from our stakeholders was to focus on PCOs more 
directly related to the test and the testing process 
itself, rather than less direct (or indirect) impacts of 
the test on ‘downstream’ clinical management deci-
sions and outcomes. We acknowledge there is limited 
literature to evaluate the validity, reliability and 
rigour of consensus methods,32 but we believe the 
methods used fulfil the criteria proposed by Hasson 
et al, namely credibility, applicability, auditability 
and confirmability.48 We used a process of prolonged 
engagement, with ongoing reflection of research 
findings both from research conducted by our team 
as well as wider literature, and based draft PCOs on 
evidence, and iterated on these over a period of 3 
years including teleconference and a face- to- face 
conference with a heterogeneous group of stake-
holders, representing patient, caregiver, clinician, 
researcher and industry perspectives. However, we 
acknowledge that there may now be value in further 
research to prioritise or rank the PCOs that we have 
described, using methods such as Delphi or nominal 
group technique.
The current focus on accuracy in evaluating 
imaging tests (and diagnostic tests in general) risks 
ignoring outcomes that may be meaningful from 
patients’ perspectives; it is the balance of outcomes 
that are important to patients, their caregivers and 
clinicians.49 However, patients and their clinicians 
Table 5 Factors that may modify patient- centred outcomes (PCOs) related to imaging tests
Modifier Definition/examples
Individual patient characteristics  ► Sociocultural factors may impact response to multiple components of the testing process
 ► Prior experience of the test or testing process may influence knowledge and expectations of the test’s purpose 
and acceptance of related risks
 ► Prior probability of the condition being tested for, whether actual or perceived by the patient
Test type (ie, screening, diagnostic, 
monitoring)
 ► Screening tests can lead to false positive results given large numbers of asymptomatic people being tested 
with relatively low prior probability
 ► Monitoring or surveillance for known condition (eg, cancer recurrence) can lead to anxiety in test intervals, 
and/or reassurance if results are negative
Clinical situation  ► Nature of the clinical condition being evaluated and its potential significance for that person’s healthcare may 
affect the balance of PCOs
 ► Testing in high acuity (eg, emergency department) settings may present different balance of benefits and risks 
(and prior probability of a given condition) compared with lower acuity (eg, primary care) setting
Clinicians and healthcare team  ► Perception of size and importance of test benefits and risks, based on experience, relationship with patient, 
healthcare setting, and knowledge or perception of an individual patient’s prior probability
 ► Ability (including time) to communicate indication for test is being used, relative risks and benefits
 ► Medical culture(s) may impose norms around test utilisation, acceptable levels of risk, patient expectations
Physical environment of imaging suite  ► Location in the clinic/hospital, visual appearance can influence patient emotions around the testing process
 ► Radiology staff can modify outcomes such as emotions and physical experiences through communication, 
trust and empathy
Communication of test results  ► Methods and timing of communicating results may impact the knowledge or information or emotional impact 
of the test
This table was created by the authors and no permission is required.
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currently lack information to make reasoned choices 
on the benefits and harms of diagnostic tests.50 
Incorporating PCOs into diagnostic test evaluations 
has implications for guideline developers and poli-
cymakers. Measures of patient satisfaction typically 
focus on patient experience of services provided, 
overlooking PCOs. Fulfilling outcomes that are 
important to patients may lead to greater satisfac-
tion. This can only be achieved for diagnostic testing 
if the outcomes that are important to patients are 
known and can be measured.25 51 52 Regulatory 
approval of new tests also focuses on test accuracy, 
although there is growing interest by the US Food 
and Drug Administration to consider additional 
impacts of tests in such decisions.
In order to advance the use of PCOs in research 
and implementation of imaging testing, we propose 
several next steps (box 1). First, validated measure-
ment instruments exist for only some PCOs we 
identified, and few outcomes are collected using 
information from patients; there is a need to develop 
instruments to measure the range of outcomes we 
describe.53 This may be challenging when measuring 
the value of information (knowledge) from patients’ 
perspectives, and in considering the implications of 
the modifying factors we identified. Second, we need 
to determine the relative importance of outcomes to 
each other (and particularly to test accuracy). Eval-
uating risks and benefits of a given test is likely to 
vary with the severity, prominence or impact of the 
PCO related to that test. Balancing beneficial and 
harmful, as well as short- term and long- term impacts, 
may require more quantitative or discrete choice 
methods.54 Third, improved reporting of PCOs by 
extending current reporting standards for diagnostic 
accuracy studies55 could facilitate reporting of addi-
tional test outcomes.
Finally, measuring PCOs is of little value if it fails 
to inform healthcare decision- making and quality 
of care.51 If the outcomes of imaging testing that 
are important to patients are known and can be 
measured, attempts to achieve these outcomes may 
lead to greater engagement with subsequent clin-
ical management.51 52 Currently, however, for most 
tests and testing situations, patients, caregivers and 
providers lack information on PCOs. Efforts will be 
needed to collect information of PCOs and present 
this in ways that can be used to guide decision- 
making.35 56 We anticipate that this expansion of 
methods for test evaluation will stimulate new stan-
dards for research, reporting and use of PCOs, across 
the wider field of diagnostic testing beyond imaging 
tests.
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